CCL2 Is a Negative Regulator of AMP-Activated Protein Kinase to Sustain mTOR Complex-1 Activation, Survivin Expression, and Cell Survival in Human Prostate Cancer PC3 Cells

by Hernan Roca, Zachary S. Varsos, Kenneth J. Pienta
Published 2009-12-01

Immune mediators in the tumor microenvironment of prostate cancer

by Jinlu Dai, Yi Lu, Hernan Roca, Jill M. Keller, Jian Zhang, Laurie K. McCauley, Evan T. Keller
Published 2017-03-01

Unique Pro-Inflammatory Response of Macrophages during Apoptotic Cancer Cell Clearance

by Veronica Mendoza-Reinoso, Dah Youn Baek, Adrianne Kurutz, John R. Rubin, Amy J. Koh, Laurie K. McCauley, Hernan Roca
Published 2020-02-01

The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment

by Kosuke Mizutani, Sudha Sud, Natalie A. McGregor, Gari Martinovski, Brandon T. Rice, Matthew J. Craig, Zachary S. Varsos, Hernan Roca, Kenneth J. Pienta
Published 2009-11-01

Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer.

by Hernan Roca, James Hernandez, Savannah Weidner, Richard C McEachin, David Fuller, Sudha Sud, Taibriana Schumann, John E Wilkinson, Alexander Zaslavsky, Hangwen Li, Christopher A Maher, Stephanie Daignault-Newton, Patrick N Healy, Kenneth J Pienta
Published 2013-01-01